SPATOLA, Federica
 Distribuzione geografica
Continente #
NA - Nord America 705
EU - Europa 140
AS - Asia 63
SA - Sud America 4
OC - Oceania 3
AF - Africa 1
Totale 916
Nazione #
US - Stati Uniti d'America 704
IT - Italia 71
CN - Cina 36
DE - Germania 19
SG - Singapore 17
GB - Regno Unito 11
RO - Romania 10
BE - Belgio 7
IE - Irlanda 6
RU - Federazione Russa 5
IN - India 4
AU - Australia 3
FR - Francia 3
CH - Svizzera 2
IR - Iran 2
KR - Corea 2
PE - Perù 2
SE - Svezia 2
UA - Ucraina 2
AT - Austria 1
BR - Brasile 1
CA - Canada 1
CL - Cile 1
EG - Egitto 1
HK - Hong Kong 1
JP - Giappone 1
NO - Norvegia 1
Totale 916
Città #
Fairfield 102
Chandler 100
Ashburn 69
Woodbridge 61
Ann Arbor 49
Seattle 40
Wilmington 34
Houston 33
Cambridge 27
New York 22
Des Moines 20
Altamura 18
Medford 14
Lawrence 11
Palermo 11
Princeton 11
Singapore 11
San Diego 10
Santa Clara 8
Bremen 7
Brussels 7
San Paolo di Civitate 7
Dublin 6
Beijing 5
Boardman 5
London 4
Ludwigshafen am Rhein 4
Nanjing 4
Guangzhou 3
Kilburn 3
Kumar 3
Milan 3
Nanchang 3
Shenyang 3
Tianjin 3
Venice 3
Washington 3
Changsha 2
Cologne 2
Dearborn 2
Jinan 2
Oakland 2
Pisa 2
Seongnam 2
Tulsa 2
Zhengzhou 2
Andover 1
Bethesda 1
Bobingen 1
Bordeaux 1
Central 1
Fidenza 1
Haikou 1
Hobart 1
Jiaxing 1
Leawood 1
Lima 1
Los Angeles 1
Napoli 1
New Bedfont 1
Oslo 1
Ottawa 1
Paris 1
Phoenix 1
Prineville 1
Pune 1
Redmond 1
Rome 1
Santiago 1
Scandicci 1
Sydney 1
São Paulo 1
Taiyuan 1
Tokyo 1
Verona 1
Villeurbanne 1
Zurich 1
Totale 776
Nome #
Antidiabetic drugs in NAFLD: The accomplishment of two goals at once? 164
Association Between PNPLA3 rs738409 C>G Variant and Liver-Related Outcomes in Patients with Non-alcoholic Fatty Liver Disease 131
Pharmacological therapy of non-alcoholic fatty liver disease: What drugs are available now and future perspectives 115
The burden of hepatocellular carcinoma in non-alcoholic fatty liver disease: Screening issue and future perspectives 110
FibroScan Identifies Patients With Nonalcoholic Fatty Liver Disease and Cardiovascular Damage 110
IMPACT OF NON-ALCOHOLIC FATTY LIVER DISEASE ON CARDIOVASCULAR RISK IN A GENERAL POPULATION 78
Interplay between non-alcoholic fatty liver disease and cardiovascular risk in an asymptomatic general population 69
A Genetic and Metabolic Staging System for Predicting the Outcome of Nonalcoholic Fatty Liver Disease 69
Systemic therapies for hepatocellular carcinoma: The present and the future 48
PNPLA3 rs738409 C>G Variant Predicts Fibrosis Progression by Noninvasive Tools in Nonalcoholic Fatty Liver Disease 46
Biochemical biomarkers of NAFLD/NASH 46
Totale 986
Categoria #
all - tutte 4.561
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.561


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020179 0 0 2 22 12 43 21 17 26 12 23 1
2020/2021201 6 16 20 34 12 6 19 11 15 25 23 14
2021/2022161 10 19 5 6 3 3 5 22 16 17 29 26
2022/2023249 27 60 2 36 21 50 13 14 15 0 5 6
2023/2024118 6 15 11 13 4 32 13 4 0 2 3 15
2024/202532 4 15 13 0 0 0 0 0 0 0 0 0
Totale 986